Current Status of Pharma and Biotech From a Capital Markets Perspective and the Implications for Pharma Services

This session explores the evolving dynamics of pharma and biotech through the lens of capital markets. We will examine current sector trends, including share price performance, valuations, loss of exclusivity (LOE), biotech IPO activity, and capital raising. We’ll also discuss recent M&A developments and their implications for investment in R&D and capex. Finally, we’ll assess how these shifts shape market expectations for pharma services, highlighting growth opportunities and investment priorities across the sector.